304 related articles for article (PubMed ID: 15899571)
1. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.
den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH
J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571
[TBL] [Abstract][Full Text] [Related]
2. LC-UV method development and validation for the investigational anticancer agent imexon and identification of its degradation products.
den Brok MW; Nuijen B; Hillebrand MJ; Lutz C; Opitz HG; Beijnen JH
J Pharm Biomed Anal; 2005 Jul; 38(4):686-94. PubMed ID: 15967296
[TBL] [Abstract][Full Text] [Related]
3. Validation of a HPLC method for the quantification and purity determination of SK3530 in drug substance and tablet.
Oh JG; Jang WJ; Chi SC
J Pharm Biomed Anal; 2007 Feb; 43(3):1179-84. PubMed ID: 17134866
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT.
Quaak SG; Nuijen B; Haanen JB; Beijnen JH
J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
Den Brok MW; Nuijen B; Kettenes-Van Den Bosch JJ; Van Steenbergen MJ; Buluran JN; Harvey MD; Grieshaber CK; Beijnen JH
PDA J Pharm Sci Technol; 2005; 59(5):285-97. PubMed ID: 16316064
[TBL] [Abstract][Full Text] [Related]
7. Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
den Brok MW; Nuijen B; Harms R; Buluran JN; Harvey MD; Grieshaber CK; Beijnen JH
J Oncol Pharm Pract; 2005 Mar; 11(1):13-9. PubMed ID: 16460599
[TBL] [Abstract][Full Text] [Related]
8. Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC.
Djurdjevic P; Ciric A; Djurdjevic A; Stankov MJ
J Pharm Biomed Anal; 2009 Sep; 50(2):117-26. PubMed ID: 19464135
[TBL] [Abstract][Full Text] [Related]
9. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
10. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Karakuş S; Küçükgüzel I; Küçükgüzel SG
J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
[TBL] [Abstract][Full Text] [Related]
12. HPLC determination of sodium cromoglycate in pharmaceutical dosage forms.
Radulović D; Kocić-Pesić V; Pećanac D; Zivanović L
Farmaco; 1994 May; 49(5):375-6. PubMed ID: 8080622
[TBL] [Abstract][Full Text] [Related]
13. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
14. Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high-performance liquid chromatography with ultraviolet detection.
García J; Márquez A; Ruiz R; López LF; Claro C; Lucero MJ
Biomed Chromatogr; 2006 Oct; 20(10):1024-7. PubMed ID: 16583452
[TBL] [Abstract][Full Text] [Related]
15. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
[TBL] [Abstract][Full Text] [Related]
16. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
[TBL] [Abstract][Full Text] [Related]
17. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
18. Stability indicating reversed-phase liquid chromatographic determination of metronidazole benzoate and diloxanide furoate as bulk drug and in suspension dosage form.
Mishal A; Sober D
J Pharm Biomed Anal; 2005 Sep; 39(3-4):819-23. PubMed ID: 16055294
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms.
Hadad GM; Emara S; Mahmoud WM
Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms.
Sistla R; Tata VS; Kashyap YV; Chandrasekar D; Diwan PV
J Pharm Biomed Anal; 2005 Sep; 39(3-4):517-22. PubMed ID: 15936912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
